Richard Douglas insider trades

Open-market stock purchases and sales by Richard Douglas, Director at Novavax Inc, from SEC Form 4 filings since Mar 10, 2011.

Track record: 9% of 11 scored buys are up 5% or more since purchase, averaging -57%.

Recent trades

DateStockTradeValue
Jun 20, 2026NVAX Novavax IncBought (not open market)—
Jun 18, 2026NVAX Novavax IncBought (not open market)—
Jun 18, 2026NVAX Novavax IncBought (not open market)—
Jun 17, 2026MXCT Maxcyte, IncBought (not open market)—
Jun 17, 2026MXCT Maxcyte, IncBought (not open market)—
Jun 9, 2026ALDX Aldeyra Therapeutics, IncBought (not open market)—
Jun 9, 2026ALDX Aldeyra Therapeutics, IncBought (not open market)—
Jun 9, 2026ALDX Aldeyra Therapeutics, IncBought (not open market)—
Mar 19, 2026ALDX Aldeyra Therapeutics, IncBought$98K

Companies traded

  • NVAX Novavax Inc: 7 buys, last Jun 20, 2026
  • MXCT Maxcyte, Inc: 3 buys, last Jun 17, 2026
  • ALDX Aldeyra Therapeutics, Inc: 8 buys, last Jun 9, 2026

Get free alerts when Richard Douglas files a new trade →